Is Monopar Therapeutics Inc. (MNPR) a Buy, Sell, or Hold?
NASDAQ : MNPR
Monopar Therapeutics Inc. — Analyst Ratings
$119.05 USD
$7.41 (6.64%)
- Volume
- 99.96K
- Average Volume
- 211.83K
- Market Capitalization
- $797.52M
- P/E Ratio
- -57.51
- Dividend Yield
- 0.00%
- Price Target
- $121.00
- Year High
- $120.52
- Year Low
- $29.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $56.04
Analyst Consensus Summary
Consensus Rating
Sell
13 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-1.6%
vs Current Price
Price Target
$121.00
Average TargetPrice Target Range
Lowest Target
$105.00
13.4% UPSIDE
Average Target
$121.00
Median Estimate
Highest Target
$125.00
-4.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 13
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 11 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Morgan Stanley | Maxwell Skor | $115 | $63.4 | 2026-01-09 05:11 AM | 81.4% |
| Raymond James | Chris Raymond | $123 | $87.01 | 2025-11-14 05:06 AM | 41.4% |
| Barclays | Etzer Darout | $125 | $87.82 | 2025-10-13 05:25 AM | 42.3% |